selected publications
-
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors.
Journal of medicinal chemistry.
2022
Academic Article
GET IT
Times cited: 2 -
Machine Learning Highlights Downtrending of COVID-19 Patients with a Distinct Laboratory Profile.
Health data science.
2021
Academic Article
GET IT
Times cited: 147 -
Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis Proteasome.
Journal of medicinal chemistry.
2021
Academic Article
GET IT
Times cited: 6 -
Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice.
Angewandte Chemie (International ed. in English).
2021
Academic Article
GET IT
Times cited: 13 -
Activity of Epigenetic Inhibitors against Plasmodium falciparum Asexual and Sexual Blood Stages.
Antimicrobial agents and chemotherapy.
2020
Academic Article
GET IT
Times cited: 13 -
Improvement of Asparagine Ethylenediamines as Anti-malarial Plasmodium-Selective Proteasome Inhibitors.
Journal of medicinal chemistry.
2019
Academic Article
GET IT
Times cited: 25